Le Chiffre
9th August 2007, 11:37 AM
I'm asking this question here instead of the CE forum as I would like to better understand the implications of pursuing CE marking for our as-yet un-marketed class 2b medical device.
When I enquired about ISO 13485 and CMDCAS registration, the auditor asked whether I also needed CE (which I declined at that point) - Is this to assess the QMS for suitability for CE? Doesn't 13485 and the Canadian CMDCAS provide sufficient requirements for the QMS?
Now from the product point of view, as I mentioned it's not yet being marketed so it doesn't have Health Canada or FDA approval. But these are underway. How much more work is it to obtain the CE mark, assuming 60601-1 is granted? Perhaps this product question is better asked in the CE forum...?
Just trying to get a sense of the workload and priorities to help the marketing group decide whether marketing outside of North America is sensible.
When I enquired about ISO 13485 and CMDCAS registration, the auditor asked whether I also needed CE (which I declined at that point) - Is this to assess the QMS for suitability for CE? Doesn't 13485 and the Canadian CMDCAS provide sufficient requirements for the QMS?
Now from the product point of view, as I mentioned it's not yet being marketed so it doesn't have Health Canada or FDA approval. But these are underway. How much more work is it to obtain the CE mark, assuming 60601-1 is granted? Perhaps this product question is better asked in the CE forum...?
Just trying to get a sense of the workload and priorities to help the marketing group decide whether marketing outside of North America is sensible.





